ABL Bio-Technologies Ltd has been delisted from the stock exchange.
Sector
PharmaceuticalsOpen
₹0.8Prev. Close
₹0.78Turnover(Lac.)
₹0.3Day's High
₹0.81Day's Low
₹0.7552 Week's High
₹052 Week's Low
₹0Book Value
₹17.21Face Value
₹10Mkt Cap (₹ Cr.)
0.66P/E
0EPS
0Divi. Yield
0No Record Found
No Record Found
| Y/e 31 Mar( In .Cr) | Mar-2012 | Mar-2011 | Mar-2010 | Mar-2009 |
|---|---|---|---|---|
Equity Capital | 8.2 | 8.2 | 8.2 | 8.2 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 10.36 | 10.54 | 11.13 | 32.01 |
Net Worth | 18.56 | 18.74 | 19.33 | 40.21 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2012 | Mar-2011 |
|---|---|---|
Revenue | 0 | 0.04 |
yoy growth (%) | -100 | |
Raw materials | 0 | -0.07 |
As % of sales | 0 | 168.76 |
Employee costs | -0.01 | -0.12 |
| Y/e 31 Mar( In .Cr) | Mar-2012 | Mar-2011 |
|---|---|---|
Profit before tax | -0.17 | -0.59 |
Depreciation | -0.06 | -0.06 |
Tax paid | 0 | 0 |
Working capital | 0.07 | |
Other operating items |
| Y/e 31 Mar | Mar-2012 | Mar-2011 |
|---|---|---|
Growth matrix (%) | ||
Revenue growth | -100 | |
Op profit growth | -78.11 | |
EBIT growth | -70.28 | |
Net profit growth | -70.06 |
| Particulars (Rupees in Crores.) | Mar-2016 | Mar-2015 | Mar-2014 | Mar-2013 | Mar-2012 |
|---|---|---|---|---|---|
Gross Sales | 0 | 0 | 0 | 0 | 0 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 0 | 0 | 0 | 0 | 0 |
Other Operating Income | 0.01 | 0.01 | 0 | 0 | 0 |
Other Income | 0 | 0 | 0 | 0 | 0 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,880 | 102.43 | 4,47,032.09 | 705.44 | 0.86 | 5,651.21 | 99.24 |
Divis Laboratories Ltd DIVISLAB | 6,761.1 | 71.43 | 1,83,758.68 | 598 | 0.43 | 2,578 | 578.26 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 4,406.15 | 66.81 | 1,49,223.98 | 577 | 0.14 | 2,547 | 249.82 |
Cipla Ltd CIPLA | 1,431.55 | 31.4 | 1,16,211.65 | 384.64 | 0.9 | 3,840.92 | 423.39 |
Dr Reddys Laboratories Ltd DRREDDY | 1,336.95 | 33.77 | 1,08,739.11 | -219.4 | 0.61 | 3,802.6 | 375.78 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Managing Director
K O Isaac
Director
G Subramanian
Director
V M Sankaran Nampoothiri
No 1 Wallers Lane 1st Floor,
Room 3 Mataji Complex Mount Rd,
Tamil Nadu - 600002
Tel: -
Website: http://www.ablbiotechnologies.com
Email: -
Subramanian Building,
1ST Floor No 1, Club House Road,
Chennai - 600002
Tel: 91-44-28462700
Website: www.cameoindia.com
Email: investor@cameoindia.com
Summary
ABL Bio Technologies Limited (ABL) is an India-based biotechnology company. The Company operates in three segments: formulation, research and development and the Docosahexaenoic acid (DHA) project. Th...
Read More
Reports by ABL Bio-Technologies Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.